COSTS ASSOCIATED WITH INITIATING EMPAGLIFLOZIN VERSUS OTHER ANTIHYPERGLYCEMIC AGENTS IN PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE: A RETROSPECTIVE COHORT STUDY

被引：0
|
作者：
Pimple, P. [1 ]
Raju, A. [2 ]
Stafkey-Mailey, D. [2 ]
Shetty, S. [1 ]
机构：
[1] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA
[2] Xcenda LLC, Palm Harbor, FL USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.605
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB56
引用
收藏
页码：S149 / S149
页数：1
相关论文
共 50 条
  • [1] Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
    Raju, Aditya
    Pimple, Pratik
    Stafkey-Mailey, Dana
    Farrelly, Eileen
    Shetty, Sharash
    [J]. DIABETES THERAPY, 2022, 13 (01) : 25 - 42
  • [2] Healthcare Costs and Resource Utilization Associated with the Use of Empagliflozin Versus Other Antihyperglycemic Agents Among Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Real-World Retrospective Cohort Analysis
    Aditya Raju
    Pratik Pimple
    Dana Stafkey-Mailey
    Eileen Farrelly
    Sharash Shetty
    [J]. Diabetes Therapy, 2022, 13 : 25 - 42
  • [3] Real-world comparison of hospitalization costs for heart failure in type 2 diabetes mellitus patients with established cardiovascular disease treated with canagliflozin versus other antihyperglycemic agents
    Chen, Yen-Wen
    Voelker, Jennifer
    Tunceli, Ozgur
    Pericone, Christopher D.
    Bookhart, Brahim
    Durkin, Michael
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2020, 23 (04) : 401 - 406
  • [4] Direct costs associated with initiating NPH insulin versus glargine in patients with type 2 diabetes: A retrospective database analysis
    Lee, Lauren J.
    Yu, Andrew P.
    Johnson, Scott J.
    Birnbaum, Howard G.
    Atanasov, Pavel
    Buesching, Don P.
    Jackson, Jeffrey A.
    Davidson, Jaime A.
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 87 (01) : 108 - 116
  • [5] Periodontal Treatment and the Risks of Cardiovascular Disease in Patients with Type 2 Diabetes: A Retrospective Cohort Study
    Peng, Chiung-Huei
    Yang, Yi-Sun
    Chan, Kuei-Chuan
    Kornelius, Edy
    Chiou, Jeng-Yuan
    Huang, Chien-Ning
    [J]. INTERNAL MEDICINE, 2017, 56 (09) : 1015 - 1021
  • [6] Cardiovascular Mortality Reduction With Empagliflozin in Patients With Type 2 Diabetes and Cardiovascular Disease
    Fitchett, David
    Inzucchi, Silvio E.
    Lachin, John M.
    Wanner, Christoph
    van de Borne, Philippe
    Mattheus, Michaela
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    George, Jyothis T.
    Zinman, Bernard
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (03) : 364 - 367
  • [7] Total costs of care in patients with type 2 diabetes and cardiovascular disease: a comparative cohort study (OFFSET)
    Evans, M.
    Chandramouli, A. Shankar
    Faurby, M.
    Matthiessen, K. Sommer
    BredahlMogensen, P.
    Verma, S.
    [J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 140 - 141
  • [8] Acute pancreatitis risk in type 2 diabetes patients treated with canagliflozin versus other antihyperglycemic agents: an observational claims database study
    Yuan, Zhong
    DeFalco, Frank
    Wang, Lu
    Hester, Laura
    Weaver, James
    Swerdel, Joel N.
    Freedman, Amy
    Ryan, Patrick
    Schuemie, Martijn
    Qiu, Rose
    Yee, Jacqueline
    Meininger, Gary
    Berlin, Jesse A.
    Rosenthal, Norman
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2020, 36 (07) : 1117 - 1124
  • [9] A stepwise approach for pharmacists: Cardiovascular risk reduction with novel antihyperglycemic agents in patients with type 2 diabetes and atherosclerotic cardiovascular disease
    Underwood, Logan
    Semchuk, William
    Albers, Lori
    [J]. CANADIAN PHARMACISTS JOURNAL, 2021, 154 (01) : 30 - 35
  • [10] Healthcare costs and hospitalizations in US patients with type 2 diabetes and cardiovascular disease: A retrospective database study (OFFSET)
    Evans, Marc
    Chandramouli, Abhishek Shankar
    Faurby, Mads
    Matthiessen, Kasper Sommer
    Mogensen, Phillip Bredahl
    Verma, Subodh
    [J]. DIABETES OBESITY & METABOLISM, 2022, 24 (07): : 1300 - 1309
12345